Evidence map›Paper›PMID 26681806›Full record

ArticleHuman molecular genetics2016

Genome-wide DNA methylation study identifies genes associated with the cardiovascular biomarker GDF-15.

Weronica E Ek, Åsa K Hedman, Stefan Enroth, Andrew P Morris, Cecilia M Lindgren, Anubha Mahajan, Stefan Gustafsson, Ulf Gyllensten, Lars Lind, Åsa Johansson

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Late-Life Depression is Associated With Increased Levels of GDF-15, a Pro-Aging Mitokine.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Clinical epigenomics for cardiovascular disease: Diagnostics and therapies.Journal of molecular and cellular cardiology · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Weronica E EkDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, and weronica.ek@igp.uu.se.
Åsa K HedmanDepartment of Medical Sciences, Molecular epidemiology and Science for Life Laboratory, Uppsala University, Uppsala 75108, Sweden.
Stefan EnrothDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, and.
Andrew P MorrisDepartment of Biostatistics, University of Liverpool, Liverpool L69 3BX, UK, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK and.
Cecilia M LindgrenWellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK and.
Anubha MahajanWellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK and.
Stefan GustafssonDepartment of Medical Sciences, Molecular epidemiology and Science for Life Laboratory, Uppsala University, Uppsala 75108, Sweden.
Ulf GyllenstenDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, and.
Lars LindDepartment of Medical Sciences, Cardiovascular Epidemiology, Uppsala University Hospital, Uppsala 75185, Sweden.
Åsa JohanssonDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, and.
Science for Life Laboratory · SEUniversity of Oxford · GBUppsala University Hospital · SE

Funding

Wellcome Trust 098017
6 · The paper itself

Abstract

Growth-differentiation factor 15 (GDF-15) is expressed in low to moderate levels in most healthy tissues and increases in response to inflammation. GDF-15 is associated with cardiovascular dysfunction and over-expressed in the myocardium of patients with myocardial infarction (MI). However, little is known about the function of GDF-15 in cardiovascular disease, and the underlying regulatory network of GDF-15 is not known. To investigate a possible association between GDF-15 levels and DNA methylation, we performed a genome-wide DNA methylation study of white blood cells in a population-based study (N = 717). Significant loci where replicated in an independent cohort (N = 963). We also performed a gene ontology (GO) enrichment analysis. We identified and replicated 16 CpG-sites (false discovery rate [FDR] < 0.05), at 11 independent loci including MIR21. MIR21 encodes a microRNA (miR-21) that has previously been shown to be associated with the development of heart disease. Interestingly, GDF15 mRNA contains a binding site for miR-21. Four sites were also differentially methylated in blood from participants previously diagnosed with MI and 14 enriched GO terms (FDR < 0.05, enrichment > 2) were identified, including 'cardiac muscle cell differentiation'. This study shows that GDF-15 levels are associated with differences in DNA methylation in blood cells, and a subset of the loci are also differentially methylated in participants with MI. However, there might be interactions between GDF-15 levels and methylation in other tissues not addressed in this study. These results provide novel links between GDF-15 and cardiovascular disease.

Indexed as

DNA MethylationAdolescentAdultAgedAged, 80 and overBiomarkersCardiovascular DiseasesCpG IslandsDNAFemaleGenome-Wide Association StudyGrowth Differentiation Factor 15HumansMaleMicroRNAsMiddle AgedBiomarkersDNAGDF15 protein, humanGrowth Differentiation Factor 15MicroRNAsMIRN21 microRNA, human

Identifiers

PMID26681806
PMCPMC5557339
OpenAlexW2256730460

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.